<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(6)</volume><submitter>Borgonetti V</submitter><pubmed_abstract>Mood disorders represent one of the most prevalent and costly psychiatric diseases worldwide. The current therapies are generally characterized by several well-known side effects which limit their prolonged use. The use of herbal medicine for the management of several psychiatric conditions is becoming more established, as it is considered a safer support to conventional pharmacotherapy. The aim of this study was to investigate the possible anxiolytic and antidepressant activity of a fixed combination of L-theanine, &lt;i>Magnolia officinalis&lt;/i>, and &lt;i>Melissa officinalis&lt;/i> (TMM) in an attempt to evaluate how the multiple modulations of different physiological systems may contribute to reducing mood disorders. TMM showed an anxiolytic-like and antidepressant-like activity in vivo, which w</pubmed_abstract><journal>Nutrients</journal><pagination>E1803</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7353338</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Novel Therapeutic Approach for the Management of Mood Disorders: In Vivo and In Vitro Effect of a Combination of L-Theanine, &lt;i>Melissa&lt;/i> &lt;i>officinalis&lt;/i> L. and &lt;i>Magnolia officinalis&lt;/i> Rehder &amp; E.H. Wilson.</pubmed_title><pmcid>PMC7353338</pmcid><pubmed_authors>Governa P</pubmed_authors><pubmed_authors>Biagi M</pubmed_authors><pubmed_authors>Galeotti N</pubmed_authors><pubmed_authors>Borgonetti V</pubmed_authors></additional><is_claimable>false</is_claimable><name>Novel Therapeutic Approach for the Management of Mood Disorders: In Vivo and In Vitro Effect of a Combination of L-Theanine, &lt;i>Melissa&lt;/i> &lt;i>officinalis&lt;/i> L. and &lt;i>Magnolia officinalis&lt;/i> Rehder &amp; E.H. Wilson.</name><description>Mood disorders represent one of the most prevalent and costly psychiatric diseases worldwide. The current therapies are generally characterized by several well-known side effects which limit their prolonged use. The use of herbal medicine for the management of several psychiatric conditions is becoming more established, as it is considered a safer support to conventional pharmacotherapy. The aim of this study was to investigate the possible anxiolytic and antidepressant activity of a fixed combination of L-theanine, &lt;i>Magnolia officinalis&lt;/i>, and &lt;i>Melissa officinalis&lt;/i> (TMM) in an attempt to evaluate how the multiple modulations of different physiological systems may contribute to reducing mood disorders. TMM showed an anxiolytic-like and antidepressant-like activity in vivo, which w</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jun</publication><modification>2026-05-03T00:08:46.532Z</modification><creation>2020-11-22T12:30:37Z</creation></dates><accession>S-EPMC7353338</accession><cross_references><pubmed>32560413</pubmed><doi>10.3390/nu12061803</doi></cross_references></HashMap>